# DAXXIFY
> **BLA761127** · Biologics License Application · Sponsor: REVANCE THERAPEUTICS, INC. · Approved 2022-09-07
## Drug
- **FDA Application Number:** BLA761127
- **Application type:** Biologics License Application
- **Brand name:** DAXXIFY
- **Generic name:** BOTULINUM TOXIN TYPE A
- **Active ingredients:** DAXIBOTULINUMTOXINA-LANM
- **Dosage form:** INJECTABLE
- **Route:** INTRAMUSCULAR, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** REVANCE THERAPEUTICS, INC.
- **Manufacturer:** Revance Therapeutics, Inc.
- **First approval:** 2022-09-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761127)
---
*AI Analytics · CC0 1.0*